S.P.Apparels Ltd. Q1FY18 Result Update

Similar documents
S P Apparels Ltd.: Q2FY18 Result Update

Trident Ltd.: Q1FY18 Result Update

Trident Ltd: Q2FY18 Result Update

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

PNC Infratech Ltd.: Q3FY18 Result Update

Dilip Buildcon Ltd.: Q3FY18 Result Update

RELIANCE INDUSTRIES LIMITED

Zee Learn Ltd.: Q2FY18 Result Update

Economic Spotlight. Current Account Deficit Narrows. Edelweiss Investment Research

Economic Spotlight. Revised Govt. Borrowing Means More Fiscal Room. Edelweiss Investment Research

Ratnamani Metals & Tubes Ltd.: Q1FY18 Results Update

Transformer and Rectifier (India) Ltd: Q4FY17 Result Update

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

Kirloskar Brothers Ltd.: Q1FY18 Result Update

Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH

First Flash: Butterfly Gandhimathi Appliances Ltd

Performance Tracker Equity

Kirloskar Brothers Ltd.: Q4FY17 Result Update

Edelweiss Investment Research Stock view: Axis Bank Ltd. Axis Bank Ltd.

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 1QFY18 Result Update

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Cummins India Ltd Bloomberg Code: KKC IN

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Visaka Industries Ltd

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Key estimate revision. Financial summary. Year

Near-term pressure, but long-term outlook positive

Jamna Auto Industries

Fineotex Chemical Ltd

Adani Ports & SEZ Rating: Target price: EPS:

Change EPS. (Rs) FY

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

HINDUSTAN UNILEVER Indulekha allure for the tresses

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Hold Target Price: Rs 574

Indo Count Industries BUY

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Amber Enterprises India Ltd

Colgate-Palmolive (India)

Institutional Equities

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

Indian Oil Corporation

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Dr Reddy s Laboratories

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Century Plyboards (India)

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

ITC Ltd. RESULT UPDATE 27th October, 2017

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Colgate-Palmolive India Ltd.

TTK Prestige. Channel-check takeaways Growth recovery pace sees moderation, competitive headwinds continue to prevail. Target CMP. Rating Rs.

Symphony Ltd. RESULT UPDATE 31st October 2017

Initiating Coverage. Uflex Ltd.

Ahluwalia Contracts (India)

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Britannia Industries Ltd.

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Balkrishna Industries Ltd

Vakrangee Ltd BUY. Speciality Retail. Company Update. Aug 07, Vakrangee Ltd. Recommendation (Rs.)

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Mahindra & Mahindra Ltd.

Simplex Infrastructures

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

UPL Ltd BUY. A consistent outperformer in a challenging industry. 30 April 2018 India Chemicals Company Update

Transcription:

Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Edelweiss Investment Research S.P.Apparels Ltd. Q1FY18 Result Update Delivering in line with guidance inspite of multiple headwinds CMP INR 398 Target INR 550 Rating: BUY Upside: 38% S.P.Apparels Ltd. (SPAL) reported a 5% revenue degrowth (adjusted for forex gains of INR 5.6 Cr) which was slightly below our expectations of a 2-3% growth, mainly due to currency volatility and the impact felt because of Brexit. The domestic retail brand Crocodile also witnessed pressure with a 1% de-growth due to GST. However inspite of these challenges and high cotton prices and currency movements, adjusted EBITDA at INR 28 cr degrew by 3% with adjusted EBITDA margins increasing from 17.9% in Q1FY17 to 18.2% in Q1FY18. Although GST and the uncertainity related to duty drawback, could impact Q2FY18 margins, we feel that the company is performing admirably inspite of many headwinds such as GST and Brexit. Commencement of shipments to new clients should start reflecting from Q2FY18 onwards and hence we continue to maintain our BUY rating with a target price of INR 550. Garments division results in line with guidance inspite of multiple headwinds; New client shipments underway Q1FY18 witnessed Brexit pressures, as subdued growth on account of Brexit, pushed retailers to take price cuts which substantially reduced SPAL s ability to negotiate with the retailers to pass on the Pound depreciation. Due to the inability to negotiate, SPAL refrained from taking certain orders to protect their margin which has led to a slight de-growth. This is a prudent strategy as Q2FY18 had resulted in a better enviornment due to diminshing Brexit effects and thus SPAL has been able to restart orders from some of the older clients. SPAL has also started shipments to 2 of the 3 new clients which should aid topline from the next quarter. The capex plans are on track as the awaited building plan approval for the spinning facility should be received in a month. The completion of this facility will lead to backward integration and improve EBITDA margins in FY19. Margins in Q2FY18 however could be impacted by 100-200 bps due to GST (Jobwork and imports taxed at 5% under GST 0% earlier with no input tax benefits as company is availing duty drawback). Kshitij Kaji Research Analyst kshitij.kaji@edelweissfin.com Bloomberg: SPAL:IN 52-week range (INR): 484 / 265 Share in issue (cr): 2 M cap (INR cr): 1,032 Avg. Daily Vol. BSE/NSE :( 000): 25 One off dents Crocodile; Strategy change seems prudent The domestic retail brand Crocodile also witnessed pressure with a 1% de-growth as GST led to a sales return of INR 4 Cr which is a significant portion as Crocodile did revenues of INR 11 Cr in Q1FY18. EBITDA losses narrowed significantly from negative EBITDA margins of 10% in Q1FY17 to negative 2% in Q1FY18. The company has changed their distribution strategy by focusing on expanding the Crocodile brand through the Large Format Stores rather than through EBOs. They have shut down 3 non performing COCO stores this quarter and they plan to ramp up their presence in LFS from 140 stores currently to 300 in 2 years entailing a lower capex of INR 8 Cr over 2 years. Public, 39.9 Promoter, 60.1 Outlook and valuations: Attractive; Re-iterate Strong BUY Topline growth of 20%, operating margin improvement and deleveraging should result in a high 46% CAGR bottomline growth from FY16 to FY19E and will trigger a re-rating. We recommend a BUY with a price target of INR 550 valuing SPAL at 13x FY19E P/E. 170 (INR cr) Q1FY18 Q1FY17 % change FY17 FY18E FY19E 150 Income from operations 151 162-5% 623 775 932 Growth % 17 24 20 EBITDA 28 29-3% 123 151 186 Adjusted net profit 11 12-4% 57 80 106 Growth % 65 42 32 130 110 90 70 50 Diluted P/E (x) 17 12 9 RoACE (%) 16 20 23 SP Apparels Sensex EV/EBITDA (x) 10 7 5 Date: 16 th August 2017 1 GWM/Edelweiss Investment Research

S.P.Apparels Ltd. Q1FY18 Result Highlights Q1FY18 Q1FY17 %Change FY17 FY18E FY19E Revenues 151 162-7% 623 775 932 Gain from forex fluctuation 5 2 150% 18 NA NA Total revenues 156 164-5% 640 775 932 COGS 59 61-3% 254 294 354 Gross Profit 97 103-6% 400 480 578 Employee Expenses 38 37 3% 147 182 219 Total expenses 69 74-7% 277 329 391 EBITDA 28 29-3% 123 151 186 Depreciation 5 4 25% 20 25 27 EBIT 23 25-8% 103 126 159 Interest expenses 7 8-13% 14 14 12 Other income 5 1 NA 4 9 10 MTM Forex loss/exceptional 4 0 NA -2 NA NA PBT 17 18-3% 94 121 158 Provision for tax 6 6 0% 33 40 52 PAT 11 12-4% 61 80 106 2 GWM/Edelweiss Investment Research

S.P.Apparels Ltd. About the Company S.P. Apparels (SPAL) is India s leading manufacturer and exporter of infants & children s garments (knitwear segment) in the 0-8 years category to UK s marquee retailers Tesco, Primark, ASDA, Mothercare and Dunnes. Although the company s growth has been subdued over the past 5 years, the recent balance sheet clean up has set the stage for aggressive surge, apparent in the 33% top line spurt in H1FY17. Incremental orders from fast growing clients and expansion to new geographies (US) are envisaged to yield sustained 18-20% top-line growth. Moreover, higher backward integration and tailwinds from government incentives for textile exporters are anticipated to spur SPAL s operating margin. We are convinced that burgeoning order book, entry in new export markets, and a lean balance sheet are key ingredients that will enable SPAL spin a commendable growth story. Investment Theme Niche capability and strong ties with marquee global retailers SPAL is a differentiated childrenswear exporter as it manufactures design-specific medium-sized orders of 20,000-50,000 pieces as opposed to competitors, which manufacture simple bulk orders of 1,00,000 plus pieces. The company s USP is that it is actively involved in design development as its core competency lies in understanding latest fashion trends to suit customer s preferences. Ergo, its realisations are almost 3x competitors. Also, SPAL has proven its ability to adhere to highest standards of safety and quality norms which are mandatory for childrenswear. This niche has helped the company establish its credentials and forge long-term alliances with UK s marquee retailers. Revitalised balance sheet to spur garments division; Crocodile s expansion to spruce up domestic revenue A high debt to equity of 5.0x in FY12 and 2.2x in FY16 offered SPAL very little room to pursue aggressive growth despite burgeoning interest from potential clients. Exotic currency hedging options of INR8cr were rolled over on the advice of banks, leading to a ballooning payment obligation and a final settlement at INR85cr, which sapped the balance sheet. However, debt, which stood at INR392cr in FY12, has dipped to INR175cr and the debt to equity has plummeted significantly to 0.4x currently. Hence, we estimate SPAL s garment division to post 15-20% CAGR over FY16-19 versus 7.4% CAGR over FY12-16 due to higher financial freedom. Moreover, we envisage Primark to spearhead surge and growth can be further accentuated by adding 1-2 more customers from non-uk regions. Expansion of the retail brand Crocodile in the domestic market is also bound to spur growth (currently domestic revenue constitutes mere 10% of total). Backward integration and deleveraging exercise potent bottom-line boosters SPAL has chalked out a comprehensive plan to utilise INR215cr of IPO proceeds to complete the backward integration process and prune debt. The backward integration plan to change the count of spinning capacity to suit its needs coupled with a new knitting facility and balancing of dyeing facility will help the company be full vertically integrated. This will boost EBITDA margin by at least 200bps. Additionally, debt repayment of close to INR75cr will provide a further leg up to the bottom line, which is estimated to clock 46% CAGR over FY16-19. Key Risks Customer and geographic concentration risk alongwith risk of stagnating customer growth Changes in domestic and international regulations and other events such as Brexit Increasing competition from other unorganized and international players Long term profitable growth in the retail division remains unclear 3 GWM/Edelweiss Investment Research

S.P.Apparels Ltd. Financials Income statement (Standalone) (INR Cr) Balance sheet (Standalone) (INR cr) Ratios Year to March FY15 FY16 FY17 FY18E FY19E As on 31st March FY15 FY16 FY17 FY18E FY19E Year to March FY15 FY16 FY17 FY18E FY19E Income from operations 473 533 623 775 932 Equity share capital 17 17 24 24 24 ROAE (%) 14.0 36.8 22.9 19.0 20.5 Direct costs 225 224 245 294 354 Preference Share Capital 27 20 21 21 21 ROACE (%) 11.6 15.2 15.8 20.2 23.0 Employee costs 100 121 146 182 219 Reserves & surplus 59 96 358 438 544 Debtors (days) 57 56 56 56 56 Other expenses 179 224 273 329 391 Shareholders funds 103 133 403 483 589 Current ratio 2.0 2.4 3.3 3.2 3.3 Total operating expenses 404 448 518 623 745 Secured loans 216 230 151 80 50 Debt/Equity 2.7 2.2 0.4 0.3 0.2 EBITDA 69 85 105 151 186 Unsecured loans 60 59 0 59 59 Inventory (days) 83 87 85 83 81 Depreciation and amortisation 20 20 22 25 27 Borrowings 276 288 151 130 100 Payable (days) 80 65 65 65 65 EBIT 49 65 83 126 159 Sources of funds 374 415 554 613 689 Cash conversion cycle (days) 60 78 76 74 72 Interest expenses 31 25 13 14 12 Gross block 417 436 480 530 555 Debt/EBITDA 4.0 3.4 1.4 0.9 0.5 Other income 7 5 21 9 10 Depreciation 141 159 182 207 234 Adjusted debt/equity 2.6 2.1 0.3 0.0 (0.1) Profit before tax 24 45 90 121 158 Net block 275 277 298 323 321 Provision for tax 15 11 33 40 52 Total fixed assets 275 281 298 323 321 Valuation parameters Core profit 10 34 57 80 106 Investments 1 1 66 5 5 Year to March FY15 FY16 FY17 FY18E FY19E Extraordinary items -0 0 0 0 0 Inventories 107 128 102 176 207 Diluted EPS (INR) 6.0 20.3 23.4 33.2 43.7 Profit after tax 10 34 57 80 106 Sundry debtors 74 82 135 119 143 Y-o-Y growth (%) 50.9 239.5 15.5 42.1 31.6 Adjusted net profit 10 35 57 80 106 Cash and equivalents 7 11 35 106 143 CEPS (INR) 17.8 32.0 32.6 43.7 54.9 Equity shares outstanding (mn) 2 2 2 2 2 Loans and advances 32 31 57 71 86 Diluted P/E (x) 67.2 19.8 17.1 12.1 9.2 EPS (INR) basic 6.0 20.3 23.4 33.2 43.7 Total current assets 220 251 330 472 578 Price/BV(x) 6.5 5.2 2.4 2.0 1.6 Diluted shares (Cr) 1.7 1.7 2.4 2.4 2.4 Sundry creditors and others 103 95 93 137 165 EV/Sales (x) 2.0 1.8 1.7 1.3 1.0 EPS (INR) fully diluted 6.0 20.3 23.4 33.2 43.7 Provisions 9 10 9 9 10 EV/EBITDA (x) 13.7 11.3 10.3 6.6 5.0 Total CL & provisions 112 105 101 147 175 Diluted shares O/S 1.7 1.7 2.4 2.4 2.4 Common size metrics- as % of net revenues Net current assets 108 146 228 325 403 Basic EPS 6.0 20.3 23.4 33.2 43.7 Year to March FY15 FY16 FY17 FY18E FY19E Net Deferred tax -32-37 -40-40 -40 Basic PE (x) 67.2 19.8 17.1 12.1 9.2 Operating expenses 85.4 84.0 83.1 80.5 80.0 Uses of funds 374 415 554 613 689 Dividend yield (%) 0.0 0.0 0.0 0.0 0.0 Depreciation 4.2 3.8 3.6 3.3 2.9 Book value per share (INR) 61 77 167 200 244 Interest expenditure 6.6 4.7 2.2 1.8 1.2 EBITDA margins 14.6 16.0 16.9 19.5 20.0 Cash flow statement Net profit margins 2.1 6.5 9.1 10.4 11.3 Year to March FY15 FY16 FY17 FY18E FY19E Net profit 10 34 57 80 106 Growth metrics (%) Add: Depreciation 20 20 22 25 27 Year to March FY15 FY16 FY17 FY18E FY19E Gross cash flow 39 57 105 107 133 Revenues 4.8 12.8 16.9 24.4 20.3 Less: Changes in W. C. -21 34 58 26 41 EBITDA 7.9 23.8 23.0 43.9 23.3 Operating cash flow 60 23 47 81 92 PBT 106.0 83.7 100.4 34.3 30.6 Less: Capex 11 25 40 50 25 Net profit 50.1 252.8 65.5 42.1 31.6 Free cash flow 49-2 7 31 67 EPS 50.9 239.5 15.5 42.1 31.6 4 GWM/Edelweiss Investment Research

Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 S.P.Apparels Ltd. Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period 170 150 130 110 90 70 50 SP Apparels Sensex 5 GWM/Edelweiss Investment Research

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Brijmohan Bohra, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. 18001023335/022-42722200/022-40094279 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. 6 GWM/Edelweiss Investment Research

Disclaimer A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 7 GWM/Edelweiss Investment Research